{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:32:34Z","timestamp":1791052354677,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1002\/jps.21233","type":"journal-article","created":{"date-parts":[[2008,1,16]],"date-time":"2008-01-16T19:16:43Z","timestamp":1200511003000},"page":"3483-3493","source":"Crossref","is-referenced-by-count":74,"title":["Fluoroquinolone Efflux Mediated by ABC Transporters"],"prefix":"10.1016","volume":"97","author":[{"given":"Ana I.","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio G.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gracia","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.21233_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.jac.a020889","article-title":"Quinolone generations: Natural history or natural selection","volume":"46","author":"Ball","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.21233_bb0015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1469-0691.2005.01131.x","article-title":"Quinolones in 2005: An update","volume":"11","author":"Van Bambeke","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1002\/jps.21233_bb0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3201\/eid0702.010239","article-title":"Emerging mechanisms of fluoroquinolone resistance","volume":"7","author":"Hooper","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1002\/jps.21233_bb0025","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/jac\/dkg224","article-title":"Antibiotic efflux pumps in prokaryotic cells: Occurrence, impact on resistance and strategies for the future of antimicrobial therapy","volume":"51","author":"Van Bambeke","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.21233_bb0030","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jac\/dkg225","article-title":"Antibiotic efflux pumps in eukaryotic cells: Occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics","volume":"51","author":"Van Bambeke","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.21233_bb0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0924-8579(00)00192-8","article-title":"The fluoroquinolone antibacterials: Past, present and future perspectives","volume":"16","author":"Appelbaum","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1002\/jps.21233_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tvjl.2005.07.010","article-title":"Pharmacology of the fluoroquinolones: A perspective for the use in domestic animals","volume":"172","author":"Martinez","year":"2006","journal-title":"Vet J"},{"key":"10.1002\/jps.21233_bb0045","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1128\/JB.89.4.1068-1074.1965","article-title":"Mechanism of action of nalidixic acid on Escherichia coli","volume":"89","author":"Goss","year":"1965","journal-title":"J Bacteriol"},{"key":"10.1002\/jps.21233_bb0050","first-page":"9","article-title":"Mechanism of action of nalidixic acid and its congeners","volume":"3","author":"Crumplin","year":"1980","journal-title":"Top Antibiot Chem"},{"key":"10.1002\/jps.21233_bb0055","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2165\/00003495-199447060-00003","article-title":"Quinolone antibacterials. An update of their pharmacology and therapeutic use","volume":"47","author":"Von Rosenstiel","year":"1994","journal-title":"Drugs"},{"key":"10.1002\/jps.21233_bb0060","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1086\/321846","article-title":"Quinolone molecular structure\u2013activity relationships: What we have learned about improving antimicrobial activity","volume":"33","author":"Peterson","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1002\/jps.21233_bb0065","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/AAC.31.4.614","article-title":"Monocyclic and tricyclic analogs of quinolones: Mechanism of action","volume":"31","author":"Georgopapadakou","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.21233_bb0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jac\/30.4.409","article-title":"The molecular basis of quinolone action","volume":"30","author":"Maxwell","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.21233_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/jmbi.1994.1586","article-title":"The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase","volume":"242","author":"Willmott","year":"1994","journal-title":"J Mol Biol"},{"key":"10.1002\/jps.21233_bb0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/.61.3.377-392.1997","article-title":"DNA gyrase, topoisomerase IV, and the 4-quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol Mol Biol"},{"key":"10.1002\/jps.21233_bb0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.pa.34.040194.001203","article-title":"DNA topoisomerases: Essential enzymes and lethal targets","volume":"34","author":"Chen","year":"1994","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1002\/jps.21233_bb0090","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.survophthal.2004.01.005","article-title":"Fluoroquinolones: Mechanism of action, classification, and development of resistance","volume":"49","author":"Blondeau","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1002\/jps.21233_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2165\/00003088-199222010-00004","article-title":"Ofloxacin clinical pharmacokinetics","volume":"22","author":"Lamp","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.21233_bb0100","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.2165\/00003088-198900161-00004","article-title":"Pharmacokinetic disposition of quinolones in human body fluids and tissues","volume":"16","author":"S\u00f6rgel","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.21233_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0732-8893(90)90095-D","article-title":"Transintestinal elimination of ciprofloxacin","volume":"13","author":"Rohwedder","year":"1990","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1002\/jps.21233_bb0110","first-page":"2506","article-title":"Intestinal elimination of ofloxacin enantiomers in the rat: Evidence of a carrier-mediated process","volume":"36","author":"Rabbaa","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.21233_bb0115","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/infdis\/165.2.322","article-title":"J774 macrophages secrete antibiotics via organic anion transporters","volume":"165","author":"Cao","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1002\/jps.21233_bb0120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1476-5381.1993.tb12844.x","article-title":"Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers","volume":"108","author":"Griffiths","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1002\/jps.21233_bb0125","first-page":"496","article-title":"Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway","volume":"269","author":"Griffiths","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21233_bb0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1012823120935","article-title":"Complete characterization of the human ABC gene family","volume":"33","author":"Dean","year":"2001","journal-title":"J Bioenerg Biomembr"},{"key":"10.1002\/jps.21233_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1002\/jps.21233_bb0140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/1389203023380521","article-title":"Multidrug resistance and cancer: The role of the human ABC transporter AB CG2","volume":"3","author":"Ejendal","year":"2002","journal-title":"Curr Protein Pept Sci"},{"key":"10.1002\/jps.21233_bb0145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1043-6618(03)00158-0","article-title":"P-Glycoprotein inhibitors and their screening: A perspective from bioavailability enhancement","volume":"48","author":"Varma","year":"2003","journal-title":"Pharmacol Res"},{"key":"10.1002\/jps.21233_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1567201043480036","article-title":"The role of ABC transporters in drug resistance, metabolism and toxicity","volume":"1","author":"Glavinas","year":"2004","journal-title":"Curr Drug Deliv"},{"key":"10.1002\/jps.21233_bb0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1002\/jps.21233_bb0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejps.2005.12.003","article-title":"Transporters as a determinant of drug clearance and tissue distribution","volume":"27","author":"Shitara","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.21233_bb0165","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1128\/AAC.42.10.2607","article-title":"Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors","volume":"42","author":"Cormet-Boyaka","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.21233_bb0170","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0022-3565(24)37842-5","article-title":"Transport of quinolone antibacterial drugs in a kidney epithelial cell line, LLC- PK1","volume":"287","author":"Matsuo","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21233_bb0175","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/dmd.105.008219","article-title":"Breast cancer resistance protein (BCRP\/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion","volume":"34","author":"Merino","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.21233_bb0180","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1124\/jpet.300.3.1063","article-title":"Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo","volume":"300","author":"Yamaguchi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21233_bb0185","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.mjt.0000132643.69143.64","article-title":"Cotransport of macrolide and fluoroquinolones, a beneficial interaction reversing P-glycoprotein efflux","volume":"11","author":"Sikri","year":"2004","journal-title":"Am J Ther"},{"key":"10.1002\/jps.21233_bb0190","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1248\/bpb.22.707","article-title":"Stereoselective permeation of new fluorinated quinolone derivatives across LLC-PK1 cell monolayers","volume":"22","author":"Sasaya","year":"1999","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.21233_bb0195","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJMra020526","article-title":"Pharmacogenomics and drug disposition, drug targets, and side effects","volume":"348","author":"Evans","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/jps.21233_bb0200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ddr.10361","article-title":"Recent advances in pharmacogenetic approaches to anticancer drug development","volume":"62","author":"Smith","year":"2004","journal-title":"Drug Dev Res"},{"key":"10.1002\/jps.21233_bb0205","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0076-6879(05)00024-8","article-title":"The genetics of ATP-binding cassette transporters","volume":"400","author":"Dean","year":"2005","journal-title":"Methods Enzymol"},{"key":"10.1002\/jps.21233_bb0210","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1473-3099(02)00369-9","article-title":"Fluoroquinolone resistance among Grampositive cocci","volume":"2","author":"Hooper","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1002\/jps.21233_bb0215","doi-asserted-by":"crossref","unstructured":"Drlica K, Malik M. 2003. Fluoroquinolones: Action and resistance: Current topics in medical chemistry 3: 249\u2013282.","DOI":"10.2174\/1568026033452537"},{"key":"10.1002\/jps.21233_bb0220","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1023\/B:PHAM.0000016247.44589.f1","article-title":"Effect of cisplatin-induced acute renal failure on bioavailability and intestinal secretion of quinolone antibacterial drugs in rat","volume":"21","author":"Yamaguchi","year":"2004","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21233_bb0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200262010-00002","article-title":"A critical review of the fluoroquinolones: Focus on respiratory infections","volume":"62","author":"Zhanel","year":"2002","journal-title":"Drugs"},{"key":"10.1002\/jps.21233_bb0230","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.bjp.0706974","article-title":"Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters","volume":"150","author":"Schrickx","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1002\/jps.21233_bb0235","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2885.2006.00744.x","article-title":"Interaction of enrofloxacin with breast cancer resistance protein (BCRP\/ABCG2): Influence of flavonoids and role in milk secretion in sheep","volume":"29","author":"Pulido","year":"2006","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1002\/jps.21233_bb0240","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/sj.bjp.0701302","article-title":"Fluoroquinolone (ciprofloxacin) secretion by human intestinal epithelial (Caco-2) cells","volume":"121","author":"Cavet","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1002\/jps.21233_bb0245","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/sj.bjp.0702703","article-title":"Active intestinal elimination of ciprofloxacin in rats: Modulation by different substrates","volume":"127","author":"Dautrey","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1002\/jps.21233_bb0250","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.bjp.0704560","article-title":"Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells","volume":"135","author":"Lowes","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1002\/jps.21233_bb0255","first-page":"360","article-title":"Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2","volume":"295","author":"Yamaguchi","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21233_bb0260","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0014-2999(01)01448-0","article-title":"Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2","volume":"431","author":"Yamaguchi","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/jps.21233_bb0265","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/AAC.46.2.344-349.2002","article-title":"Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats","volume":"46","author":"Naruhashi","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.21233_bb0270","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1124\/dmd.104.003442","article-title":"Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells","volume":"33","author":"Xia","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.21233_bb0275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/10611860500087835","article-title":"Kinetic modelling of the intestinal transport of sarafloxacin. Studies in situ in rat and in vitro in Caco-2 cells","volume":"13","author":"Fernandez-Teruel","year":"2005","journal-title":"J Drug Target"},{"key":"10.1002\/jps.21233_bb0280","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-3565(24)36787-4","article-title":"Carrier-mediated hepatic uptake of quinolone antibiotics in the rat","volume":"282","author":"Sasabe","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21233_bb0285","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0022-3565(24)37330-6","article-title":"Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats","volume":"284","author":"Sasabe","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21233_bb0290","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3565(24)37277-5","article-title":"Stereoselective hepatobiliary transport of the quinolone antibiotic grepafloxacin and its glucuronide in the rat","volume":"284","author":"Sasabe","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21233_bb0295","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1440-1681.2002.03627.x","article-title":"Possible involvement of P-glycoprotein in the biliary excretion of grepafloxacin","volume":"29","author":"Zhao","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1002\/jps.21233_bb0300","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1124\/jpet.104.065201","article-title":"Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice","volume":"310","author":"Sasabe","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21233_bb0305","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/AAC.44.6.1697-1700.2000","article-title":"Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells","volume":"44","author":"Terashi","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.21233_bb0310","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1124\/dmd.107.014969","article-title":"Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones","volume":"35","author":"Ando","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.21233_bb0315","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1128\/AAC.42.2.456","article-title":"Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats","volume":"42","author":"Foote","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.21233_bb0320","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1023\/A:1018871029244","article-title":"Distribution characteristics of levofloxacin and grepafloxacin in rat kidney","volume":"16","author":"Ito","year":"1999","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21233_bb0325","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1023\/A:1007533817835","article-title":"Transepithelial transport of levofloxacin in the isolated perfused rat kidney","volume":"17","author":"Ito","year":"2000","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21233_bb0330","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0022-3565(24)36897-1","article-title":"Transport of quinolone antibacterial drugs by human P-Glycoprotein expressed in a kidney epithelial cell line, LLC-PK1","volume":"282","author":"Ito","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21233_bb0335","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1248\/bpb.20.887","article-title":"The transport of ciprofloxacin in cultured kidney epithelial cells LLC-PK1","volume":"20","author":"Sasaya","year":"1997","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.21233_bb0340","first-page":"146","article-title":"Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier","volume":"295","author":"Tamai","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21233_bb0345","first-page":"784","article-title":"Quantitative brain microdialysis study on the mechanism of quinolones distribution in the central nervous system","volume":"25","author":"Ooie","year":"1997","journal-title":"Drug Metab Disp"},{"key":"10.1002\/jps.21233_bb0350","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-3565(24)37029-6","article-title":"Kinetic evidence for active efflux transport across the blood-brain barrier of quinolone antibiotics","volume":"283","author":"Ooie","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21233_bb0355","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1128\/AAC.42.10.2756","article-title":"A new approach for early assessment of the epileptogenic potential of quinolones","volume":"42","author":"Delon","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.21233_bb0360","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0928-0987(00)00149-4","article-title":"In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin","volume":"12","author":"Lange","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.21233_bb0365","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1158\/0008-5472.CAN-03-2033","article-title":"Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier","volume":"64","author":"Cisternino","year":"2004","journal-title":"Cancer Res"},{"key":"10.1002\/jps.21233_bb0370","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nm1186","article-title":"The breast cancer resistance protein BCRP (ABCG2) concentrates drug and carcinogenic xenotoxins into milk","volume":"11","author":"Jonker","year":"2005","journal-title":"Nat Med"},{"key":"10.1002\/jps.21233_bb0375","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2133\/dmpk.20.491","article-title":"Carrier-mediated uptake of grepafloxacin, a fluoroquinolone antibiotic, by the isolated rat lung cells","volume":"20","author":"Sasabe","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1002\/jps.21233_bb0380","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bcp.2006.11.015","article-title":"Functional studies on the activity of efflux transporters in an ex vivo model with chicken splenocytes and evaluation of selected fluoroquinolones in this model","volume":"73","author":"Haritova","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/jps.21233_bb0385","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/jac\/dkg223","article-title":"Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus","volume":"51","author":"Seral","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.21233_bb0390","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1128\/AAC.49.6.2429-2437.2005","article-title":"Related articles, influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages","volume":"49","author":"Michot","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.21233_bb0395","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1128\/AAC.50.5.1689-1695.2006","article-title":"Cellular accumulation and activity of quinolones in ciprofloxacin-resistant J774 macrophages","volume":"50","author":"Michot","year":"2006","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916326867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916326867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T20:40:26Z","timestamp":1737837626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916326867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":78,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0022354916326867"],"URL":"https:\/\/doi.org\/10.1002\/jps.21233","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}